xovoltib 30mg tablet - Afatinib dimaleate (30mg) medicine

Xovoltib 30mg Tablet (Afatinib): Comprehensive Medicine Guide

No reviews yet
🏭 Boehringer Ingelheim 📦 Varies by brand 💊 Allopathy 📅 Updated: Oct 17, 2026
⚠️ Hepatotoxicity Risk ⚠️ Nephrotoxicity Risk 🤰 Pregnancy Category This medicine can cause fetal harm when administered to a pregnant woman. Based on its mechanism of action and animal studies, it is expected to be harmful to the developing fetus. Women of childbearing potential should use effective contraception during treatment and for at least 2 weeks after the last dose. If pregnancy occurs during treatment, the patient should be informed of the potential risk to the fetus. 📋 Prescription Required 💊 Generic Available
Medically Reviewed
12 min read
Evidence: Well-established for approved indications.
Reviewed by
SaathiMed Expert Panel | Oct 17, 2026
🩺
Medically Fact-Checked & Clinically Verified by SaathiMed Clinical Review Board
Clinical Reference Standards: CDSCO (Central Drugs Standard Control Organisation), Indian Pharmacopoeia (IP) & WHO | Last Updated: September 2026

When to Call Your Doctor IMMEDIATELY

  • Severe diarrhoea (more than 6 loose stools per day) or signs of dehydration such as dizziness, dry mouth, or reduced urine output.
  • New or worsening cough, shortness of breath, or fever, which may indicate interstitial lung disease.
  • Severe skin rash with blisters, peeling skin, or sores in the mouth or eyes.
  • Yellowing of the skin or eyes, dark urine, or right upper abdominal pain, which may indicate liver problems.
  • Eye pain, redness, blurred vision, or excessive tearing.
  • Chest pain, palpitations, or swelling of the legs, which may indicate heart problems.
  • Severe abdominal pain with fever or blood in stool, which may indicate gastrointestinal perforation.
  • Unusual bruising or bleeding.
  • Muscle pain, weakness, or dark urine, which may indicate rhabdomyolysis.

If experiencing severe symptoms, call emergency services immediately.

What is xovoltib 30mg tablet used for?

This medicine is a targeted cancer therapy used to treat EGFR mutation-positive non-small cell lung cancer. It works by blocking specific receptors on cancer cells to slow their growth. It is taken orally once daily under the supervision of a cancer specialist.

  • Generic Name: Afatinib dimaleate (30mg)
  • Manufacturer: Boehringer Ingelheim
  • Form: Allopathy
  • Pregnancy Category: Consult doctor
  • Prescription Required: Yes

🇮🇳 xovoltib 30mg tablet के बारे में (Hindi Summary)

उपयोग: यह दवा मुख्य रूप से उन फेफड़ों के कैंसर (नॉन-स्मॉल सेल लंग कैंसर) के इलाज के लिए इस्तेमाल की जाती है, जिनमें EGFR जीन में विशेष म्यूटेशन होता है। यह एक टार्गेटेड थेरेपी है, जो कैंसर कोशिकाओं के विकास को रोकने में मदद करती है। यह दवा मुँह से ली जाती है और डॉक्टर की सलाह से ही लेनी चाहिए। यह कैंसर को पूरी तरह ठीक नहीं करती, लेकिन बीमारी को नियंत्रित करने और जीवन की गुणवत्ता सुधारने में मदद करती है।

साइड इफेक्ट्स: इस दवा के सामान्य दुष्प्रभावों में दस्त, त्वचा पर दाने, मुँह के छाले, नाखूनों में सूजन, भूख कम लगना, जी मिचलाना और थकान शामिल हैं। दस्त गंभीर हो सकते हैं, इसलिए पर्याप्त पानी पिएं। त्वचा पर लाल चकत्ते या छाले होने पर तुरंत डॉक्टर को बताएं। कुछ गंभीर दुष्प्रभाव जैसे फेफड़ों में सूजन, लीवर की समस्या, आंखों में दर्द या धुंधली दृष्टि भी हो सकते हैं, जिनके लिए तत्काल चिकित्सा सहायता लेनी चाहिए।

सुरक्षा सलाह: इस दवा को केवल कैंसर विशेषज्ञ की देखरेख में ही लें। रोज एक ही समय पर दवा लें, खाने के साथ या बिना। अंगूर और अंगूर का जूस न लें, क्योंकि इससे दवा का स्तर बढ़ सकता है। गर्भावस्था के दौरान इस दवा का इस्तेमाल न करें, क्योंकि यह शिशु के लिए हानिकारक हो सकती है। स्तनपान कराने वाली महिलाएं इस दवा का सेवन न करें। दवा लेते समय शराब से बचें। धूप में जाने से बचें और सनस्क्रीन का इस्तेमाल करें। नियमित रूप से डॉक्टर से जांच कराते रहें।

💡 Did You Know? India is the largest provider of generic medicines globally, supplying over 50% of global vaccine demand.

💊 xovoltib 30mg tablet Uses & Benefits

  • [{"condition":"EGFR mutation-positive advanced non-small cell lung cancer (NSCLC)","description":"This medicine is used as first-line treatment for patients with locally advanced or metastatic NSCLC whose tumours have certain activating EGFR mutations, such as exon 19 deletions or exon 21 L858R substitution.
  • It helps shrink tumours and delay progression.","evidence":"Well-established"},{"condition":"Squamous cell carcinoma of the lung (after platinum-based chemotherapy)","description":"This medicine is approved for patients with advanced squamous NSCLC whose disease has progressed after platinum-based chemotherapy.
  • It provides an additional treatment option in this setting.","evidence":"Well-established"},{"condition":"Head and neck cancer (off-label)","description":"Sometimes used off-label in recurrent or metastatic head and neck squamous cell carcinoma, especially in patients with EGFR overexpression.
  • Evidence is limited and it is not a standard first-line option.","evidence":"Limited"}]

Off-label uses: [{"condition":"HER2-positive breast cancer","description":"Afatinib has been studied in HER2-positive breast cancer, particularly in combination with other targeted therapies, but it is not approved for this indication. Use is investigational.","evidence":"Limited"},{"condition":"Other EGFR-mutated solid tumours","description":"Rarely, this medicine may be used in other cancers with EGFR mutations, such as certain colorectal or brain tumours, but evidence is very limited and it is not standard practice.","evidence":"Limited"}]

Primary treatment for: EGFR mutation-positive advanced non-small cell lung cancer (NSCLC)

Also treats: Squamous cell carcinoma of the lung (after platinum-based chemotherapy), Head and neck cancer (off-label), HER2-positive breast cancer (off-label, investigational)

📋 Drug Information

Generic Name(s)Afatinib dimaleate (30mg)
Brand Namexovoltib 30mg tablet
ManufacturerBoehringer Ingelheim
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassANTI NEOPLASTICS
Action ClassTyrosine kinase inhibitors
Route of AdministrationOral
StorageStore at room temperature between 15°C and 30°C (59°F to 86°F). Keep the tablets in their original blister pack or bottle, tightly closed, and protect from moisture and light. Do not remove the desiccant from the bottle. Keep out of reach of children and pets.
Shelf LifeThe shelf life of this medicine is typically 24 to 36 months from the date of manufacture. Refer to the expiry date printed on the packaging. Do not use after the expiry date.
WHO GuidelineNot established from the available information.
ICMR GuidelineNot established from the available information.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1
Take this medicine at the same time each day to maintain steady blood levels.
2
Monitor for diarrhoea and start anti-diarrhoeal treatment early if needed; stay hydrated.
3
Use gentle skin care and moisturisers to manage rash; report severe rash to your doctor.
4
Avoid grapefruit and grapefruit juice as they can increase drug levels and side effects.
5
Use effective contraception during treatment and for at least 2 weeks after the last dose.
6
Report any new or worsening cough, shortness of breath, or fever immediately, as it may indicate lung problems.
7
Have regular blood tests to check liver and kidney function as advised by your doctor.
8
Inform your doctor if you experience eye pain, redness, or blurred vision.
9
Do not stop taking this medicine without consulting your doctor, even if you feel better.
10
Keep all appointments for monitoring and follow-up to ensure safe and effective treatment.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

✅
Chronic cough and shortness of breath in a lung cancer patient
This medicine is used to treat EGFR mutation-positive lung cancer and may improve these symptoms.
Likely Use
✅
Skin rash and diarrhoea
These are common side effects of this medicine, not a reason to stop without consulting your doctor.
Likely Use
❌
Fever with cough and breathlessness
This could indicate a serious lung problem or infection. Seek immediate medical attention.
Not Primary
❌
Severe abdominal pain with blood in stool
This may indicate gastrointestinal perforation, a medical emergency. Seek immediate care.
Not Primary

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionFollowing oral administration, this medicine is absorbed from the gastrointestinal tract, with peak plasma concentrations typically reached within 2 to 5 hours. The absolute bioavailability is approximately 59% in healthy volunteers. Food does not significantly affect the extent of absorption, but it can reduce the peak concentration slightly. Steady-state plasma levels are reached within 8 days of once-daily dosing.
DistributionThis medicine is widely distributed throughout the body. It has a high volume of distribution, indicating extensive tissue distribution. It is approximately 95% bound to plasma proteins, mainly albumin and alpha-1-acid glycoprotein. The distribution is not significantly affected by age, sex, or renal function.
Protein BindingApproximately 95% bound to plasma proteins, primarily albumin and alpha-1-acid glycoprotein.
MetabolismThis medicine undergoes minimal metabolism. It is mainly metabolised by cytochrome P450 enzymes, primarily CYP3A4, but the extent of metabolism is low. The parent drug is the predominant circulating species. No major active metabolites have been identified.
Half-LifeThe terminal elimination half-life of this medicine is approximately 28 to 36 hours, supporting once-daily dosing.
ExcretionThis medicine is primarily eliminated in the faeces (approximately 85% of the dose), with a smaller amount excreted in the urine (approximately 4%). The majority of the dose is excreted as unchanged drug.
BioavailabilityThe absolute bioavailability of this medicine is approximately 59% after oral administration.
Onset of ActionThe onset of clinical effect is not immediate. It may take several weeks of continuous treatment before tumour response or symptom improvement is observed. Steady-state plasma levels are reached within 8 days.
Peak Plasma TimePeak plasma concentrations are reached approximately 2 to 5 hours after oral administration.
Duration of ActionThe duration of action is related to the irreversible binding to EGFR family receptors. The inhibitory effect persists until new receptors are synthesised, which supports once-daily dosing. The clinical effect lasts as long as the medicine is taken regularly.

How It Works

This medicine works by irreversibly binding to and inhibiting the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) family, which includes EGFR (ErbB1), HER2 (ErbB2), ErbB3, and ErbB4. These receptors are involved in signalling pathways that promote cell growth, survival, and division. In certain cancers, mutations or overexpression of these receptors lead to uncontrolled cell proliferation. By blocking these receptors, this medicine interrupts the signalling cascade, leading to reduced cancer cell growth and increased cell death. Because the binding is irreversible, the inhibitory effect lasts until new receptors are synthesised.

Mechanism Steps

1
Binding to EGFR family receptors: This medicine enters cancer cells and binds irreversibly to the intracellular tyrosine kinase domain of EGFR, HER2, ErbB3, and ErbB4.
2
Inhibition of receptor autophosphorylation: By binding to the kinase domain, this medicine prevents the receptor from phosphorylating itself and downstream signalling proteins.
3
Blockade of downstream signalling: This blocks the activation of pathways such as MAPK and PI3K/AKT, which are important for cancer cell growth and survival.
4
Reduced cancer cell proliferation and survival: With these signals blocked, cancer cells stop dividing and may undergo programmed cell death (apoptosis).
5
Tumour growth inhibition: The overall effect is slowing or stopping tumour growth, which may lead to tumour shrinkage and clinical improvement.

💡 How to Take xovoltib 30mg tablet

Strength: This medicine is available as an immediate-release tablet containing 30 mg of afatinib dimaleate. It is also available in other strengths such as 20 mg, 40 mg, and 50 mg.

1Take this medicine at the same time each day, with or without food.
2Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet.
3If you have trouble swallowing, consult your doctor for alternative options.
4Avoid grapefruit and grapefruit juice while taking this medicine.
5If you miss a dose, follow the missed dose instructions provided by your doctor.
6Do not take an extra dose to make up for a missed one.
7Keep a record of your doses and side effects to discuss with your doctor.

Dosage Information

Adult DosageThe recommended adult dose of this medicine is 40 mg taken orally once daily, but for this 30 mg strength, the dose may be adjusted by the doctor. The typical starting dose for EGFR mutation-positive NSCLC is 40 mg once daily, and for squamous NSCLC after platinum-based chemotherapy, it is also 40 mg once daily. However, the 30 mg tablet is often used when a dose reduction is needed due to side effects. Dose reductions may be made in steps of 10 mg. The maximum daily dose is 50 mg, but this is rarely used. Dose must be individualized by a qualified clinician based on indication, age, weight, renal and hepatic function, and tolerability. Do not change the dose without consulting your doctor.
Pediatric DosagePediatric dosing is not established from available information. Consult a pediatric oncologist for guidance.
Elderly DosageNo specific dose adjustment is recommended for elderly patients based on age alone. However, elderly patients may be more sensitive to side effects such as diarrhoea and dehydration. Monitor closely and adjust dose as needed based on tolerability and organ function.
Renal ImpairmentNo dose adjustment is required for patients with mild to moderate renal impairment (creatinine clearance 30-89 mL/min). For severe renal impairment (creatinine clearance <30 mL/min), caution is advised and dose adjustment may be considered based on clinical judgment. Not established for patients on dialysis.
Hepatic ImpairmentNo dose adjustment is required for patients with mild to moderate hepatic impairment (Child-Pugh A or B). For severe hepatic impairment (Child-Pugh C), this medicine should be used with caution and dose adjustment may be necessary. Monitor liver function closely.
Maximum Daily DoseThe maximum recommended daily dose is 50 mg, but the usual maximum is 40 mg once daily. Dose reductions to 30 mg or 20 mg may be needed for toxicity. Do not exceed the dose prescribed by your doctor.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

🍽️ Food Timing Guide

With or without food
Take at the same time each day
Food does not significantly affect absorption, but taking it consistently helps maintain steady levels.
Grapefruit and grapefruit juice
Avoid
May increase drug levels and side effects by inhibiting CYP3A4.
St. John's wort
Avoid
May decrease drug levels and reduce effectiveness by inducing CYP3A4 and P-gp.

⏰ What to Do If You Miss a Dose

📌 Less than 12 hours until next scheduled dose
→ Skip the missed dose.
💡 Do not double dose. Continue with your regular schedule.
📌 More than 12 hours until next scheduled dose
→ Take the missed dose as soon as you remember.
💡 Then continue with your regular schedule.

⚠️ Side Effects of xovoltib 30mg tablet

✅ Common Side Effects

Diarrhoea (Very common (>10%))
Drink plenty of fluids to avoid dehydration. If diarrhoea is severe or persists, contact your doctor, as dose adjustment or additional treatment may be needed.
Skin rash (acne-like) (Very common (>10%))
Use gentle skin care, avoid harsh soaps, and apply moisturiser. Your doctor may prescribe a topical antibiotic or steroid. Report worsening rash.
Dry skin (Very common (>10%))
Use fragrance-free moisturisers regularly. Avoid hot showers and harsh detergents.
Itching (Common (1-10%))
Keep skin moisturised and avoid scratching. Consult your doctor if itching is severe.
Mouth sores (stomatitis) (Common (1-10%))
Maintain good oral hygiene, avoid spicy or acidic foods, and use a soft toothbrush. Your doctor may recommend a mouth rinse.
Nail inflammation (paronychia) (Common (1-10%))
Keep nails clean and dry, avoid cutting nails too short, and report any redness or pain around nails to your doctor.
Decreased appetite (Common (1-10%))
Eat small, frequent meals and choose nutritious foods. Consult a dietitian if weight loss occurs.
Nausea (Common (1-10%))
Take the tablet with food if it helps. Your doctor may prescribe anti-nausea medicine if needed.
Fatigue (Common (1-10%))
Get adequate rest and pace your activities. Report persistent or worsening fatigue to your doctor.

🚨 Serious Side Effects

Severe diarrhoea and dehydration (Uncommon (0.1-1%))
Seek immediate medical attention if you have more than 6 loose stools per day, feel dizzy, or have reduced urine output. You may need intravenous fluids.
Interstitial lung disease (ILD) (Rare (<0.1%))
Seek immediate medical help if you develop new or worsening cough, shortness of breath, or fever. This medicine may need to be stopped permanently.
Severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis) (Rare (<0.1%))
Stop the medicine and seek emergency care if you develop a painful rash with blisters, peeling skin, or sores in the mouth or eyes.
Liver problems (hepatitis, liver failure) (Uncommon (0.1-1%))
Report yellowing of skin or eyes, dark urine, or right upper abdominal pain immediately. Your doctor will monitor liver enzymes regularly.
Eye problems (keratitis) (Uncommon (0.1-1%))
Seek prompt ophthalmological evaluation if you experience eye pain, redness, blurred vision, or excessive tearing.
Heart problems (reduced ejection fraction) (Uncommon (0.1-1%))
Report symptoms such as shortness of breath, swelling of legs, or palpitations. Your doctor may check your heart function.
Gastrointestinal perforation (Very rare (<0.01%))
Seek emergency care for severe abdominal pain, fever, or blood in stool. This is a medical emergency.

⚠️ Rare Side Effects

Pancreatitis
Seek immediate medical attention for severe upper abdominal pain that may radiate to the back, with nausea and vomiting.
Rhabdomyolysis
Report muscle pain, weakness, or dark urine immediately. This requires urgent medical evaluation.
Thrombocytopenia
Report unusual bruising or bleeding. Your doctor will monitor your blood counts.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug Severity Effect
Ketoconazole Major
Rifampicin Major
Verapamil Moderate
Omeprazole Moderate
Warfarin Minor
Ibuprofen Minor
St. John's wort Major
Clarithromycin Major
Phenytoin Major
Cyclosporine Moderate

🚨 Major Interactions

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin, ritonavir)
  • Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine, phenytoin, St. John's wort)
  • P-glycoprotein (P-gp) inhibitors (e.g., verapamil, quinidine, cyclosporine)
  • P-glycoprotein (P-gp) inducers (e.g., rifampicin, St. John's wort)

⚡ Moderate Interactions

  • Proton pump inhibitors (e.g., omeprazole)
  • H2 receptor antagonists (e.g., ranitidine)
  • Antacids

🍷 Alcohol Interaction

Alcohol may worsen some side effects of this medicine, such as nausea, fatigue, and liver stress. It is advisable to avoid or limit alcohol consumption while taking this medicine. Consult your doctor for personalised advice.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Known hypersensitivity to afatinib or any component of the tablet","Pregnancy (due to risk of fetal harm)","Breastfeeding (due to potential serious adverse reactions in infants)","Severe hepatic impairment (Child-Pugh C) without close monitoring","Concomitant use with strong CYP3A4 inducers (unless benefits outweigh risks and dose adjusted)"]

⚠️ Warnings & Precautions

["Diarrhoea: May be severe and lead to dehydration. Monitor and treat promptly.","Skin reactions: May be severe; monitor and manage with appropriate skin care and medications.","Interstitial lung disease: Rare but potentially fatal. Discontinue if suspected.","Hepatotoxicity: Monitor liver function tests. Discontinue if severe.","Cardiotoxicity: Monitor cardiac function in at-risk patients.","Eye disorders: Keratitis may occur. Refer to ophthalmologist if symptoms develop.","Embryo-fetal toxicity: Use effective contraception during treatment and for at least 2 weeks after the last dose.","Lactation: Do not breastfeed during treatment and for at least 2 weeks after the last dose.","Renal impairment: Use with caution in severe renal impairment.","Gastrointestinal perforation: Rare but serious. Discontinue if suspected."]

🤱 Lactation Safety

It is not known whether this medicine is excreted in human milk. Because of the potential for serious adverse reactions in breastfed infants, women should not breastfeed during treatment and for at least 2 weeks after the last dose.

💊 Overdose Management

There is no specific antidote for overdose with this medicine. In case of suspected overdose, treatment should be symptomatic and supportive. Monitor vital signs and manage any adverse reactions. Contact a poison control centre or emergency department immediately. Haemodialysis is not expected to be effective because afatinib is highly protein-bound.

⏰ Missed Dose

If you miss a dose and it is more than 12 hours until your next scheduled dose, take the missed dose as soon as you remember. If it is less than 12 hours until your next dose, skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for a missed one.

Additional Safety Advice

General Safety

This medicine must only be taken under the supervision of a qualified cancer specialist. Do not start, stop, or change the dose without consulting your doctor. Take the tablet at the same time each day, with or without food, but avoid grapefruit and grapefruit juice as they can increase the amount of medicine in your body. If you miss a dose and it is more than 12 hours until your next scheduled dose, take it as soon as you remember; if it is less than 12 hours, skip the missed dose and continue with your regular schedule. Do not double the dose. Because this medicine can cause diarrhoea and skin problems, your doctor will monitor you regularly with blood tests and physical examinations. Use effective contraception during treatment and for at least 2 weeks after the last dose if you are of childbearing potential. Do not breastfeed while taking this medicine. Avoid prolonged sun exposure and use sunscreen, as this medicine can make your skin more sensitive to sunlight. Inform all your healthcare providers, including your dentist, that you are taking this medicine before any procedure. Keep this medicine out of the reach of children and store it as directed on the label.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients (above 65 years) may be more sensitive to the side effects of this medicine, especially diarrhoea and dehydration. Close monitoring is recommended. Dose adjustment may be needed based on tolerability and organ function. Falls and fatigue should be managed carefully.

🤰 Pregnancy Planning (TTC)

This medicine can cause harm to the unborn baby. Women of childbearing potential should use effective contraception during treatment and for at least 2 weeks after the last dose. If you are planning to become pregnant, discuss with your doctor before stopping contraception. Men with female partners of childbearing potential should also use effective contraception during treatment and for at least 2 weeks after the last dose.

🏥 Post-Surgery Considerations

If you are scheduled for surgery, inform your surgeon and anaesthesiologist that you are taking this medicine. It may need to be stopped temporarily before surgery due to the risk of impaired wound healing and bleeding. Your doctor will advise you on when to stop and when to restart.

🦷 Dental Procedures

Inform your dentist that you are taking this medicine before any dental procedure. This medicine can cause mouth sores and may affect healing. Your dentist may recommend postponing non-urgent procedures until your blood counts and overall condition are stable. Maintain good oral hygiene to reduce the risk of complications.

💚 Lifestyle Tips for Better Results

🏃
Maintain a balanced diet rich in fruits, vegetables, and whole grains to support your immune system.
🥗
Stay well hydrated, especially if you experience diarrhoea.
😴
Use gentle, fragrance-free skin care products to manage rash.
💧
Avoid prolonged sun exposure and use sunscreen with SPF 30 or higher.
🧘
Get adequate rest and pace your activities to manage fatigue.
🌞
Practice good oral hygiene to prevent mouth sores.
🚭
Engage in light exercise as tolerated to maintain strength and well-being.
🥑
Avoid alcohol and smoking, as they can worsen side effects and overall health.

🏋️ Exercise Considerations

This medicine may cause fatigue, dizziness, or eye problems that could affect your ability to exercise safely. Avoid strenuous activities if you feel unwell. Consult your doctor before starting any new exercise programme. Light activities such as walking may be beneficial, but listen to your body and rest when needed.

🥗 Diet Recommendations

Eat small, frequent meals if you have nausea or decreased appetite.
Include protein-rich foods to help maintain muscle mass.
Avoid spicy, acidic, or rough-textured foods if you have mouth sores.
Drink plenty of fluids to prevent dehydration, especially if you have diarrhoea.
Avoid grapefruit and grapefruit juice.
Limit alcohol consumption.
Consider consulting a dietitian for personalised advice.

💼 Impact on Daily Work & Life

This medicine may cause fatigue, diarrhoea, skin rash, and eye problems, which can affect your ability to work and perform daily activities. You may need to take time off or adjust your work schedule during treatment. Driving and operating machinery should be avoided if you feel tired or have vision problems. Discuss with your employer about flexible working arrangements if needed. Emotional support and counselling can help cope with the impact of cancer treatment.

🛑 When to Stop This Medicine

Do not stop taking this medicine without consulting your doctor. Your doctor may decide to stop treatment if the disease progresses, if you experience unacceptable side effects, or if you develop certain serious conditions such as interstitial lung disease. If you need to stop, your doctor will guide you on how to do so safely and may discuss alternative treatments.

📅 Long-Term Use Effects

Long-term use of this medicine may lead to persistent side effects such as skin rash, diarrhoea, and fatigue. Regular monitoring of liver, kidney, and heart function is required. Some patients may develop resistance to the medicine over time, leading to disease progression. Long-term use may also increase the risk of rare but serious side effects. Your doctor will regularly assess the benefits and risks of continuing treatment.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Other EGFR tyrosine kinase inhibitors (e.g., erlotinib, gefitinib, osimertinib)

These are alternative targeted therapies for EGFR-mutated lung cancer. Your doctor may choose one based on your specific mutation and medical history.

Evidence: Well-established
Chemotherapy

Traditional chemotherapy may be used alone or in combination with targeted therapy, depending on the stage and type of cancer.

Evidence: Well-established
Immunotherapy

Immune checkpoint inhibitors may be an option for some patients with lung cancer, but they are generally less effective in EGFR-mutated tumours.

Evidence: Well-established for certain indications
Clinical trials

Participation in clinical trials may provide access to new and investigational treatments.

Evidence: Varies

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

Live vaccines should be avoided while taking this medicine because it may weaken the immune system. Inactivated vaccines are generally safe, but consult your doctor before receiving any vaccine. Timing of vaccination should be discussed with your oncologist.

📦 Storage Guide

✅ DO

Store at room temperature between 15°C and 30°C.

❌ DON'T

Do not refrigerate or freeze.

✅ DO

Keep in the original blister pack or bottle, tightly closed.

❌ DON'T

Do not transfer to another container.

✅ DO

Protect from moisture and light.

❌ DON'T

Do not store in the bathroom.

✅ DO

Keep out of reach of children and pets.

❌ DON'T

Do not use after the expiry date.

✈️ Traveling with This Medicine

When travelling, carry this medicine in its original packaging with the prescription label clearly visible. Bring a copy of your prescription and a doctor&#039;s letter explaining that you need this medicine for cancer treatment. Keep the medicine in your carry-on luggage to avoid loss or temperature extremes. Store at room temperature and protect from moisture. If crossing time zones, consult your doctor about how to adjust the timing of your dose. Check the customs regulations of your destination country regarding controlled or prescription medicines. Carry enough supply for your entire trip and a little extra in case of delays.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 58-year-old woman with EGFR mutation-positive lung cancer
She was started on this medicine after her diagnosis. Within a few weeks, she noticed improvement in her cough and breathing. She experienced mild skin rash and diarrhoea, which were managed with moisturisers and anti-diarrhoeal medication. She emphasised taking the tablet at the same time every day and avoiding grapefruit.
💡 Lesson: Adherence to daily dosing and prompt management of side effects can help patients stay on treatment and achieve better outcomes.
👤 A 65-year-old man with squamous lung cancer after chemotherapy
He was prescribed this medicine after his cancer progressed on chemotherapy. He initially had severe diarrhoea, which required a dose reduction. With careful monitoring and hydration, he was able to continue treatment and his cancer remained stable for several months.
💡 Lesson: Dose adjustments and supportive care can help manage side effects and allow patients to continue benefiting from treatment.

💬 Questions Patients Often Ask

Q: How long does it take to work?

A: It may take several weeks to months before you notice improvement. Your doctor will assess response with regular scans and tests.

Q: Can I take this medicine with food?

A: Yes, you can take it with or without food. However, avoid grapefruit and grapefruit juice.

Q: What should I do if I miss a dose?

A: If it is more than 12 hours until your next dose, take it as soon as you remember. If it is less than 12 hours, skip the missed dose and continue with your regular schedule. Do not double dose.

Q: What are the most common side effects?

A: The most common side effects are diarrhoea, skin rash, dry skin, mouth sores, and fatigue. These can usually be managed with supportive care.

Q: Is this medicine safe during pregnancy?

A: No, this medicine can harm the unborn baby. It is contraindicated during pregnancy. Use effective contraception during treatment and for at least 2 weeks after the last dose.

Q: Can I drink alcohol while taking this medicine?

A: It is best to avoid or limit alcohol as it may worsen side effects such as nausea, fatigue, and liver stress.

Q: How should I store this medicine?

A: Store at room temperature between 15°C and 30°C in the original packaging, protected from moisture and light. Keep out of reach of children.

Q: Can I stop taking this medicine if I feel better?

A: No, do not stop without consulting your doctor. Stopping early can lead to disease progression.

Q: What serious side effects should I watch for?

A: Watch for severe diarrhoea, new or worsening cough or breathlessness, severe skin reactions, yellowing of eyes or skin, eye pain, chest pain, and severe abdominal pain. Seek immediate medical attention if these occur.

Q: Does this medicine interact with other drugs?

A: Yes, it can interact with several medicines, including strong CYP3A4 inhibitors and inducers, and P-gp inhibitors. Always inform your doctor about all medicines you are taking.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

  • Can I take this medicine long-term?
  • Will it affect my kidney function?
  • Can I drive after taking this medicine?
  • Does it interact with my blood pressure medicine?
  • What if I miss a dose?
  • Can I drink alcohol while taking this?
  • Will I lose my hair?
  • Is it safe to take during pregnancy?
  • Can I take it with other cancer medicines?
  • How long does it take to work?

🔄 Substitutes for xovoltib 30mg tablet

View All

Alternative brands with exact same active ingredient:

Medical Note: Always consult your doctor before switching medications.

🛑 Myths vs. Facts

  • Myth: This medicine is a traditional chemotherapy that causes severe hair loss.
    Fact: This medicine is a targeted therapy, not traditional chemotherapy. Hair loss is not a common side effect. It mainly causes skin rash and diarrhoea.
  • Myth: This medicine can cure lung cancer completely.
    Fact: This medicine can control the disease and improve survival, but it is not a cure. It is used to slow progression and manage symptoms.
  • Myth: You can stop taking this medicine once you feel better.
    Fact: You must continue taking this medicine as prescribed by your doctor. Stopping early can lead to disease progression.
  • Myth: This medicine is safe to take during pregnancy.
    Fact: This medicine can harm the unborn baby. It is contraindicated during pregnancy, and effective contraception is required.

🔄 Alternative Options

Brand Alternatives

📊 Comparison with Similar Medicines

[{"medicine":"Afatinib (this medicine)","class":"Second-generation EGFR TKI","target":"EGFR, HER2, ErbB3, ErbB4","common_side_effects":"Diarrhoea, skin rash, stomatitis","approved_indications":"EGFR-mutated NSCLC, squamous NSCLC"},{"medicine":"Erlotinib","class":"First-generation EGFR TKI","target":"EGFR","common_side_effects":"Skin rash, diarrhoea","approved_indications":"EGFR-mutated NSCLC, pancreatic cancer"},{"medicine":"Gefitinib","class":"First-generation EGFR TKI","target":"EGFR","common_side_effects":"Skin rash, diarrhoea, liver enzyme elevation","approved_indications":"EGFR-mutated NSCLC"},{"medicine":"Osimertinib","class":"Third-generation EGFR TKI","target":"EGFR (including T790M)","common_side_effects":"Diarrhoea, skin rash, paronychia","approved_indications":"EGFR-mutated NSCLC (first-line and after resistance)"}]

😊 Was this information helpful?

Browse Medicines A-Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory